OCI Holdings Company (A010060) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
23 Dec, 2025Executive summary
Q1 sales revenue reached KRW 947 billion with operating income of KRW 49 billion and a 5.1% margin, reversing a loss from Q4 due to improved Poly-Si sales, cost normalization, and a low base effect at DCRE.
Net income was negative at KRW -15 billion, but EBITDA improved to KRW 107 billion, with an EBITDA margin of 11.4%.
Most major subsidiaries, except the chemical business, improved operating results despite a market downturn.
Financial highlights
Sales increased 10.9% quarter-over-quarter to KRW 947 billion, with operating income swinging from a loss of KRW -108 billion in Q4 2024 to a profit of KRW 49 billion in Q1 2025.
Net debt reduced to KRW 258 billion, and the debt ratio improved to 67.0%.
Net debt lowered through receivables collection, land sales, and debt repayment.
Total assets stood at KRW 7,967 billion, with a leverage ratio of 67%.
Outlook and guidance
Polysilicon operating rates to be reduced in Q2 to manage inventory and working capital.
OCI TerraSus expects normal operations in 2H 2025 as tariff and solar policy uncertainties ease, with operations adjusted in Q2 2025 due to delayed demand recovery.
U.S. solar cell production to begin in Q1 next year, with preparations on track and a target of 1 GW commercial operation.
Targeting business turnaround in the second half of the year, with new sales contracts and strategic partnerships.
DCRE to recognize sales from Complex 7 upon completion, with ongoing pre-sale and related expenses to be reflected.
Latest events from OCI Holdings Company
- Q4 2025 marked a return to profit, but FY2025 closed with a net loss amid policy headwinds.A010060
Q4 202511 Feb 2026 - Q2 revenue up 9.8%, but profit fell as U.S. solar and market risks weighed on results.A010060
Q2 20242 Feb 2026 - Q3 2024 saw a 77% drop in operating income and net loss, but investments and buybacks continue.A010060
Q3 202417 Jan 2026 - Revenue up 35% but operating profit plunged 81% as market and policy risks persisted.A010060
Q4 202423 Dec 2025 - Q2 sales fell 18% with an operating loss as policy and market headwinds drive strategic shifts.A010060
Q2 202516 Nov 2025 - Q3 sales grew and losses narrowed, with positive EBITDA and strategic supply chain moves.A010060
Q3 202511 Nov 2025